$348 Million is the total value of Integral Health Asset Management, LLC's 70 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVS | New | CVS HEALTH CORP | $12,729,000 | – | 150,000 | +100.0% | 3.66% | – |
| PFE | New | PFIZER INC | $10,753,000 | – | 250,000 | +100.0% | 3.09% | – |
| HOLX | New | HOLOGIC INC | $8,857,000 | – | 120,000 | +100.0% | 2.55% | – |
| SGEN | New | SEAGEN INC | $6,792,000 | – | 40,000 | +100.0% | 1.95% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $6,572,000 | – | 60,000 | +100.0% | 1.89% | – |
| CNC | New | CENTENE CORP DEL | $6,231,000 | – | 100,000 | +100.0% | 1.79% | – |
| DXCM | New | DEXCOM INC | $5,469,000 | – | 10,000 | +100.0% | 1.57% | – |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $5,075,000 | – | 350,000 | +100.0% | 1.46% | – |
| ARCT | New | ARCTURUS THERAPEUTICS HLDGS | $4,061,000 | – | 85,000 | +100.0% | 1.17% | – |
| ABBV | New | ABBVIE INC | $3,775,000 | – | 35,000 | +100.0% | 1.08% | – |
| ATRA | New | ATARA BIOTHERAPEUTICS INC | $3,580,000 | – | 200,000 | +100.0% | 1.03% | – |
| New | AVALO THERAPEUTICS INC | $3,543,000 | – | 1,625,000 | +100.0% | 1.02% | – | |
| MGNX | New | MACROGENICS INC | $3,350,000 | – | 160,000 | +100.0% | 0.96% | – |
| BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $2,778,000 | – | 20,000 | +100.0% | 0.80% | – |
| INSM | New | INSMED INC | $2,754,000 | – | 100,000 | +100.0% | 0.79% | – |
| INSP | New | INSPIRE MED SYS INC | $2,329,000 | – | 10,000 | +100.0% | 0.67% | – |
| RGNX | New | REGENXBIO INC | $2,306,000 | – | 55,000 | +100.0% | 0.66% | – |
| ZY | New | ZYMERGEN INC | $2,107,000 | – | 160,000 | +100.0% | 0.61% | – |
| LYEL | New | LYELL IMMUNOPHARMA INC | $2,072,000 | – | 140,000 | +100.0% | 0.60% | – |
| IMGN | New | IMMUNOGEN INC | $1,701,000 | – | 300,000 | +100.0% | 0.49% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $1,684,000 | – | 350,000 | +100.0% | 0.48% | – |
| ZYME | New | ZYMEWORKS INC | $1,452,000 | – | 50,000 | +100.0% | 0.42% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $1,393,000 | – | 50,000 | +100.0% | 0.40% | – |
| AVIR | New | ATEA PHARMACEUTICALS INC | $1,052,000 | – | 30,000 | +100.0% | 0.30% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $620,000 | – | 35,000 | +100.0% | 0.18% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.